Advancing cardiology pharmacy practice: A position paper on physician-led, pharmacist-enabled model for sustainable

Daniel Benjamin Fletcher1, Guek Leng Loh2, Grace Chang Shu-Wen3

  • 1Department of Pharmacy, Changi General Hospital, Singapore, Singapore.

Insights

Cardiology pharmacists are vital for optimizing cardiovascular care in Singapore, addressing medication safety and patient education. Enhancing their training and integrating digital tools are key priorities for future healthcare.

Area of Science:

  • Pharmacology
  • Public Health
  • Healthcare Management

Background:

  • Cardiovascular disease is a major health concern in Singapore, necessitating improved longitudinal care.
  • An ageing population and metabolic factors increase the demand for specialized cardiology pharmacy services.
  • Current limitations in specialist accreditation and service distribution hinder scalable delivery of care.

Purpose of the Study:

  • To outline key priorities for advancing cardiology pharmacy practice in Singapore.
  • To address challenges in medication optimization, care transitions, and patient education.
  • To propose a framework for a future-ready cardiovascular care ecosystem.

Main Methods:

  • Developed by the Pharmaceutical Society of Singapore Cardiology Pharmacy Working Group.
  • Utilized a multidisciplinary consensus approach guided by RIGHT and AGREE II principles.
  • Synthesized evidence from literature, national data, and institutional experience.

Main Results:

  • Cardiology pharmacists are crucial for medication safety, adherence, and dose optimization.
  • Identified gaps include delayed post-discharge follow-up and fragmented care coordination.
  • Challenges exist in telehealth implementation and specialist workforce development.

Conclusions:

  • Five priorities: workforce capability, post-discharge reviews, integrated care, digital enablement, and expanded roles.
  • Cardiology pharmacists are essential for a safe, coordinated cardiovascular care system.
  • A physician-led, pharmacist-enabled model aligns with national health goals.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
313
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
203
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
221
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
197
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
580
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
436